✨ Overview
Our high-quality TRZ-GLP/GIP peptide is available in 8mg, 10mg, 15mg, 20mg, 30mg, 60mg and 70mg sizes. The product comes in a lyophilized powder form in a 3mL vial that requires Reconstitution Solution to reconstitute from solid to liquid form.
TRZ is a novel dual agonist peptide targeting both GLP-1 and GIP receptors. It is one of the most closely studied compounds in modern obesity and diabetes research, combining satiety and glucose-regulating effects.
Areas of Ongoing Exploration
- Weight management – Research into appetite suppression and body fat reduction.
- Glucose metabolism – Studied for its strong effects on insulin sensitivity and blood sugar.
- Cardiometabolic studies – Interest in broader heart and vascular outcomes.
- Comparisons to Semaglutide – Examined as a next-generation alternative
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 8 mg, 10 mg, 15 mg, 20 mg, 30 mg, 60 mg or 70 mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: 39–amino acid GLP-1/GIP dual agonist analogue
- Molecular Formula: C₂₂₅H₃₆₆N₆₄O₆₇
- Molecular Weight: ~4813 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
